BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22619508)

  • 1. Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles.
    Vannucci L; Falvo E; Fornara M; Di Micco P; Benada O; Krizan J; Svoboda J; Hulikova-Capkova K; Morea V; Boffi A; Ceci P
    Int J Nanomedicine; 2012; 7():1489-509. PubMed ID: 22619508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers.
    Vannucci L; Falvo E; Failla CM; Carbo M; Fornara M; Canese R; Cecchetti S; Rajsiglova L; Stakheev D; Krizan J; Boffi A; Carpinelli G; Morea V; Ceci P
    J Biomed Nanotechnol; 2015 Jan; 11(1):81-92. PubMed ID: 26301302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages.
    Fantechi E; Innocenti C; Zanardelli M; Fittipaldi M; Falvo E; Carbo M; Shullani V; Di Cesare Mannelli L; Ghelardini C; Ferretti AM; Ponti A; Sangregorio C; Ceci P
    ACS Nano; 2014 May; 8(5):4705-19. PubMed ID: 24689973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
    Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
    Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy.
    Gao X; Luo Y; Wang Y; Pang J; Liao C; Lu H; Fang Y
    Int J Nanomedicine; 2012; 7():4037-51. PubMed ID: 22888241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
    Jiang H; Kasten BB; Liu H; Qi S; Liu Y; Tian M; Barnes CL; Zhang H; Cheng Z; Benny PD
    Bioconjug Chem; 2012 Nov; 23(11):2300-12. PubMed ID: 23110503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.
    Lu W; Xiong C; Zhang G; Huang Q; Zhang R; Zhang JZ; Li C
    Clin Cancer Res; 2009 Feb; 15(3):876-86. PubMed ID: 19188158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
    Fu X; Wang X; Zhou S; Zhang Y
    Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
    Chen F; Zhang X; Ma K; Madajewski B; Benezra M; Zhang L; Phillips E; Turker MZ; Gallazzi F; Penate-Medina O; Overholtzer M; Pauliah M; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Quinn TP
    ACS Appl Mater Interfaces; 2018 Feb; 10(5):4379-4393. PubMed ID: 29058865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fullerene-based multi-functional nanoplatform for cancer theranostic applications.
    Shi J; Wang L; Gao J; Liu Y; Zhang J; Ma R; Liu R; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5771-84. PubMed ID: 24746227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
    Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
    Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetite nanocluster@poly(dopamine)-PEG@ indocyanine green nanobead with magnetic field-targeting enhanced MR imaging and photothermal therapy in vivo.
    Wu M; Wang Q; Zhang D; Liao N; Wu L; Huang A; Liu X
    Colloids Surf B Biointerfaces; 2016 May; 141():467-475. PubMed ID: 26896652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Al
    Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
    Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.
    Jie LY; Cai LL; Wang LJ; Ying XY; Yu RS; Zhang MM; Du YZ
    Int J Nanomedicine; 2012; 7():3981-9. PubMed ID: 22866005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
    Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
    Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
    Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
    Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.